000 01392 a2200385 4500
005 20250516072629.0
264 0 _c20120413
008 201204s 0 0 eng d
022 _a1873-2968
024 7 _a10.1016/j.bcp.2011.12.030
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJana, Sayantan
245 0 0 _aCurcumin as anti-endometriotic agent: implication of MMP-3 and intrinsic apoptotic pathway.
_h[electronic resource]
260 _bBiochemical pharmacology
_cMar 2012
300 _a797-804 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCurcumin
_xpharmacology
650 0 4 _aDisease Models, Animal
650 0 4 _aEndometriosis
_xdrug therapy
650 0 4 _aEndometrium
_xenzymology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMatrix Metalloproteinase 3
_xmetabolism
650 0 4 _aMatrix Metalloproteinase Inhibitors
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aNF-kappa B
_xantagonists & inhibitors
700 1 _aPaul, Sumit
700 1 _aSwarnakar, Snehasikta
773 0 _tBiochemical pharmacology
_gvol. 83
_gno. 6
_gp. 797-804
856 4 0 _uhttps://doi.org/10.1016/j.bcp.2011.12.030
_zAvailable from publisher's website
999 _c21444517
_d21444517